The Tradeoffs of Rigging Medicare Drug Prices That Biden Ignored
Extracting significant savings by reducing drug prices would limit innovation, the CBO concluded.
Medicare
The Casualties of ‘Moral Imperatives’
Prohibiting profit in health care would leave people suffering from conditions that would have been alleviated or cured by private-sector innovation.
Why Amnesty Is So Costly to Social Security and Medicare
The cost is steep in part because of a fiscal benefit that illegal immigrants generate- namely, free contributions to our entitlement programs.
Don’t Cut Seniors’ Drug Coverage to Fund Another Spending Spree
Cutting Medicare payments for prescription drugs would hurt seniors and slow drug development in the process.
PSA: We’re Still Going Bankrupt
Entitlement trust funds are running out and the debt is exploding.
Obamacare’s Illusion of Preexisting Condition Protections
Prohibitive costs placed coverage outside the reach of everyday Americans, including countless with preexisting conditions.
Continued Government Failures on Drug Pricing
An executive order adds to problems stemming from existing policies, instead of freeing up competition by deregulating the U.S. market.
Trump’s Presidential Powers Seem to Be Dwindling
His staff routinely ignores him, and his threats aimed at corporations go unheeded.